GlassScriptPhysician profile
Matthew Schoenfeld
NPI 1699031773
$36,595.80
in general payments reported to CMS, 2019-2025
56 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $942 · 2020: $1,335 · 2021: $3,725 · 2022: $3,453 · 2023: $5,438 · 2024: $4,401 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $4,501 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,100 · Consulting Fee: $2,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,888.82 |
| Travel and Lodging | $4,501.27 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,100.00 |
| Consulting Fee | $2,650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,944.59 | 2019-2025 | Dragonfly Opstar, Diamondback Coronary, Ultreon |
| Medtronic, INC. | $7,237.62 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Abiomed | $3,342.95 | 2021-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $1,462.36 | 2020-2025 | Brilinta, Farxiga, Wainua |
| Boston Scientific Corporation | $1,279.36 | 2022-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, General - Tachy |
| Novartis Pharmaceuticals Corporation | $1,026.29 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $957.96 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $709.90 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $671.22 | 2020-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $653.89 | 2019-2025 | Lifevest |
| Pfizer INC. | $490.06 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $487.36 | 2020-2024 | Xarelto |
| Novo Nordisk INC | $474.76 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $422.46 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Pascal |
| Inari Medical, INC. | $416.11 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $312.80 | 2021-2024 | Verquvo |
| Bridgebio Pharma, INC. | $303.85 | 2025 | Attruby |
| Cardiovascular Systems INC. | $277.55 | 2020-2022 | |
| Atricure, INC. | $237.21 | 2023-2024 | |
| Shockwave Medical, INC | $223.34 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $219.64 | 2024-2025 | Onpattro, Amvuttra |
| Philips North America LLC | $217.16 | 2019 | |
| Sanofi-Aventis U.S. LLC | $194.58 | 2019-2023 | |
| Cvrx, INC. | $193.15 | 2023-2025 | Barostim Neo System |
| Siemens Medical Solutions USA, INC. | $151.61 | 2023-2025 | Artis Icono Biplane, Naeotom Alpha |
| Amarin Pharma, INC. | $141.57 | 2019-2022 | |
| Medtronic Vascular, INC. | $136.11 | 2020 | |
| Penumbra, INC. | $119.27 | 2024 | Indigo System |
| Impulse Dynamics (USA) INC. | $107.81 | 2021-2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $101.73 | 2024 | Arcalyst |
| Akcea Therapeutics, INC. | $90.28 | 2020 | |
| W. L. Gore & Associates, INC. | $83.56 | 2021-2022 | |
| Cardiva Medical, INC. | $75.26 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Kestra Medical Technology Services, INC. | $74.24 | 2024-2025 | Assure Wcd |
| Stryker Corporation | $72.86 | 2025 | Flowtriever |
| Terumo Medical Corporation | $69.36 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $65.54 | 2023 | Arcalyst |
| Ancora Heart, INC. | $60.50 | 2024 | Accucinch |
| Chiesi USA, INC. | $55.97 | 2022-2025 | Kengreal |
| Scpharmaceuticals INC. | $55.28 | 2023-2025 | |
| Procyrion, INC. | $43.82 | 2024-2025 | Aortix System |
| Biosense Webster, INC. | $36.11 | 2019 | |
| Tactile Systems Technology INC | $35.65 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Angiodynamics, INC. | $29.45 | 2021-2023 | Alphavac |
| Sanofi Pasteur INC. | $28.87 | 2024 | |
| Biotronik INC. | $28.49 | 2022 | |
| Teleflex LLC | $26.69 | 2019 | |
| Livanova USA, INC. | $26.21 | 2019 | |
| Daxor Corporation | $20.42 | 2023 | Bva-100 |
| Amryt Pharma Holdings LTD | $17.76 | 2021 | |
| Itamar Medical INC | $16.28 | 2022 | |
| Heartflow, INC. | $15.18 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.78 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $14.22 | 2024 | |
| Alexion Pharmaceuticals, INC. | $14.21 | 2021 | |
| Acarix USA INC. | $10.54 | 2023 | Cadscor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Schoenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.